SCHEMBL7974516

SCHEMBL7974516

CCn1cnc(NC(=O)c2ccccc2)c1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
RAB9A P51151 6/20 0.42
KDM4E B2RXH2 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPC1 O15118 4/20 0.42
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
ATM Q13315 1/20 0.39
TLR9 Q9NR96 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975241 0.86 GAA (0.50) RAB9ANPC1SMN1; SMN2ADORA3
SCHEMBL7991860 0.85 ADORA2A (0.46) HTTRAB9AKDM4ETDP1NPC1
SCHEMBL7991817 0.83 KDM4E (0.51) HTTL3MBTL1KDM4EMAPTSMN1; SMN2
SCHEMBL7984506 0.82 EHMT2 (0.43) RAB9ANPC1SMN1; SMN2ADORA3
SCHEMBL7974581 0.82 LMNA (0.51) HTTRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL7984668 0.81 POLB (0.49) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL7984694 0.81 NR1H4 (0.53) RAB9ANPC1ALDH1A1KMT2A
SCHEMBL7985416 0.81 LMNA (0.50) L3MBTL1RAB9AKDM4ENPSR1NPC1
SCHEMBL7973841 0.81 RAB9A (0.47) RAB9ANPC1ALDH1A1KMT2A
SCHEMBL7984751 0.81 NTRK1 (0.46) RAB9AKDM4ENPSR1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed